Lecture 11 - GI inpatient Flashcards
Upper GI Bleeding Major causes
inflammation, ulcers, cancer within Esophagus, gastric or Duodenal speces
Mallory-weiss tear
Misoprostol MOA
synthetic analog of prostaglandin E to replace those lost when other agents that inhibit the roduction
Sucralfate MOA
provides protective covering, not widely used.
Achgalasia
Disorder involving lower esophageal sphincter
Zollinger-Ellison’s Syndrome
Hypersecretion of gastrin due to tumor
Modifiable risk factors PUD
Multiple NSAID use Concomitant anticoagulants Corticosteroids SSRIs Tobacco use
Non-modifiable risk factors PUD
Age > 25
History of PUD
H.Pylori infectin
Acid suppression therapy recommended in patients who….
are receiving prolonged ( > 6 months) high-dose steroids or when used concomitantly with NSAIDs
PUD and SSRI therapy
- using PPIs appear to mitigate the risk
2. no really clinically relevant, would prob keep person on SSRI in practice
PUD and smoking
> 10 cig per day can increase gastric acid secretion
Stress-related mucosal damage (SMRD)
most likely to occur in critical care patients
Estimated in 75% of pts will develop within 72hrs
SMRD in critically ill patients
Coagulopathy
long time on vent
head injury
History of GI bleed
2 + of following
Sepsis, > 7 days ICU, High dose Corticosteroids > 250mg hydrocort, overt bleeding > 6 day
SMRD in non-critically ill patients
> 2 of the following
GERD Duodenal or Gastric ulcer H.pylori infection active Presumed/known upper GI bleed pts receiving antiplatelet/ aspirin therapy Receiving H2 blocker or PPI at home
Prophylaxis against PUD
Most compelling to consider in….
Chronic NSAIDs + multiple NSAIDs
Previous PUD
Concomitant use w/ corticosteroids
Less compelling to consider in…
65+
combo SSRI + NSAIDs
Prophylaxis for SRMD
hospitalized pts meeting criteria previously outlined, only while criteria is met**